NSV Partners III LP - 24 Jun 2024 Form 4 Insider Report for Ventyx Biosciences, Inc. (VTYX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
26 Jun 2024, 17:23:06 UTC
Prior SEC filing
16 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ NSV Partners III, LP, By: Brenda Marex, Chief Financial Officer, and /s/ NSV Partners III GP, LLC, By: Brenda Marex, Chief Financial Officer

Key filing fact

NSV Partners III LP filed Form 4 for Ventyx Biosciences, Inc. (VTYX) on 26 Jun 2024.

Key facts

  • This page summarizes NSV Partners III LP's Form 4 filing for Ventyx Biosciences, Inc. (VTYX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 26 Jun 2024, 17:23.

Change

  • Previous filing in this sequence was filed on 16 Apr 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

VTYX transaction

Common Stock

Other

Transaction value
$0
Shares
-641,327
Change %
-8.3%
Price
$0.000000
Shares after
7,102,969
Date
24 Jun 2024
Ownership
See Footnote
Footnotes
F1, F2, F3, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

NSV Investments I, L.P. distributed 125,651 shares of Common Stock, NSV Investments II, L.P. distributed 232,180 shares of Common Stock, and NSV Investments III, L.P. distributed 283,496 shares of Common Stock, each to their respective limited partners.

Footnote F2

NSV Partners III, L.P. is the general partner of NSV Investments I, L.P., NSV Investments II, L.P., and NSV Investments III, L.P.

Footnote F3

Somasundaram Subramaniam is the majority member and managing member of NSV Partners III GP, LLC, and may be deemed to have voting and dispositive power over the shares owned by each entity of which NSV Partners III, L.P. is general partner. Mr. Subramaniam is the majority member and managing member NSV Partners II, LLC. Mr. Subramaniam is the majority member and managing member of New Science Ventures, LLC. Mr. Subramaniam disclaims beneficial ownership over the shares owned by each of the NSV Funds (as defined below), except to the extent of his pecuniary interest therein. Mr. Subramaniam is a director of the issuer and files separate reports under Section 16 of the Securities Exchange Act of 1934, as amended.

Footnote F4

The shares beneficially owned by the reporting persons consist of: (i) 4,878,420 shares owned by NSV Investments I, L.P., (ii) 1,381,606 shares owned by NSV Partners III, L.P., (iii) 434,423 shares owned by New Science Ventures, LLC, and (iv) 408,520 shares owned by NSV Partners II, LLC (collectively, the "NSV Funds"). The NSV Funds disclaim beneficial ownership over the shares owned by them, except to the extent of their pecuniary interest therein.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .